Evidence map›Paper›PMID 31553647›Full record

ArticleAmerican journal of physiology. Cell physiology2019

Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

Pantipa Tonsawan, James Dylewski, Linda Lewis, Judith Blaine

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.International journal of molecular sciences · 2023
    Review
  7. In Translation: FcRn across the Therapeutic Spectrum.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Pantipa TonsawanDivision of Renal Disease and Hypertension, University of Colorado School of Medicine, Aurora, Colorado.
James DylewskiDivision of Renal Disease and Hypertension, University of Colorado School of Medicine, Aurora, Colorado.
Linda LewisDivision of Renal Disease and Hypertension, University of Colorado School of Medicine, Aurora, Colorado.
Judith BlaineDivision of Renal Disease and Hypertension, University of Colorado School of Medicine, Aurora, Colorado.
University of Colorado Denver · US

Funding

The Dual Role of the Neonatal Fc Receptor (FcRn) in PodocytesR01DK104264 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BLAINE, JUDITH T., · 2015 to 2024
$3.1M
NIDDK NIH HHS R01 DK104264
6 · The paper itself

Abstract

The neonatal Fc receptor (FcRn) has been shown to be required for antigen presentation in dendritic cells, and global knockout of FcRn attenuates immune-mediated kidney disease. Podocytes express interleukin-6 (IL-6) receptor and produce IL-6 under proinflammatory conditions. Here we examined the role of FcRn in the IL-6-mediated inflammatory response in podocytes. We examined IL-6 production by ELISA and expression by qPCR in wild type (WT) and FcRn knockout (KO) podocytes after treatment with proinflammatory stimuli as well as IL-6-mediated signaling via the JAK/STAT pathway. We also examined podocyte motility in cultured WT and KO podocytes after a proinflammatory challenge. We found that FcRn KO podocytes produced minimal amount of IL-6 after treatment with albumin, IgG, or immune complexes whereas WT podocytes had a robust response. FcRn KO podocytes also had minimal expression of IL-6 compared with WT. By Western blotting, there was significantly less phosphorylated STAT3 in KO podocytes after treatment with IFNγ or immune complexes. In a scratch assay, FcRn KO podocytes showed increased motility comparted KO, suggesting a defect in actin dynamics. Cultured FcRn KO podocytes also demonstrated abnormal stress fibers compared with WT and the defect could be rescued by IL-6 treatment. This study shows that in podocytes, FcRn modulates the IL-6 mediated response to proinflammatory stimuli and regulates podocytes actin structure, motility and synaptopodin expression.

Indexed as

Actin CytoskeletonAnimalsCell Line, TransformedCells, CulturedHistocompatibility Antigens Class IInterleukin-6MiceMice, KnockoutPodocytesReceptors, FcSignal TransductionFc receptor, neonatalHistocompatibility Antigens Class IInterleukin-6Receptors, Fccytoskeletonimmune mediated kidney diseaseinterleukin-6neonatal Fc receptorpodocyte

Identifiers

PMID31553647
PMCPMC6879880
OpenAlexW2976900540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.